In vitro drug release

YG Yue Gao
JN Jingxue Nai
ZY Zhenbo Yang
JZ Jinbang Zhang
SM Siyu Ma
YZ Yumei Zhao
HL Hui Li
JL Jiaxin Li
YY Yang Yang
MY Meiyan Yang
YW Yuli Wang
WG Wei Gong
FY Fanglin Yu
CG Chunsheng Gao
ZL Zhiping Li
XM Xingguo Mei
request Request a Protocol
ask Ask a question
Favorite

The in vitro drug release of nab paclitaxel was carried out in PBS containing 0.05% (W/V) Tween 20 and 0.05% (W/V) Tween 80 via a dialysis method. In brief, approximately 5mg of self-made nanoparticles or Abraxane was first suspended in 10mL of release media. Then, 3mL of the total was drawn out and put into dialysis bags (MWCO 8000–14000 Da, Beijing Henghui Co., Ltd., China), and these samples were finally immersed in 50mL of release medium under stirring at 37°C. The release medium was completely replaced with 50mL of fresh release media at predetermined times. The concentrations of paclitaxel in the release media were determined by HPLC [3, 23, 30]. For comparison, the release of paclitaxel from Taxol was also performed under the same conditions. All of the tests were performed in triplicate.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A